Lumos Diagnostics Holdings Limited (ASX:LDX)
Australia
· Delayed Price · Currency is AUD 0.0280
+0.0020 (7.69%)
May 14, 2025, 4:10 PM AEST
ASX:LDX Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2018 - 2019 |
| Revenue | 14.67 | 11.13 | 10.54 | 11.63 | 18.85 | 5.8 | Upgrade
|
| Revenue Growth (YoY) | 78.61% | 5.66% | -9.41% | -38.31% | 225.25% | 29.54% | Upgrade
|
| Cost of Revenue | 5.39 | 4.57 | 5.21 | 9.76 | 10.25 | 3.28 | Upgrade
|
| Gross Profit | 9.28 | 6.56 | 5.32 | 1.88 | 8.6 | 2.51 | Upgrade
|
| Selling, General & Admin | 11.99 | 11.5 | 11.64 | 21.89 | 18.36 | 11.32 | Upgrade
|
| Research & Development | 0.09 | 0.07 | 0.25 | 1.33 | 1.24 | 1.92 | Upgrade
|
| Operating Expenses | 14.77 | 14.22 | 15.56 | 28.78 | 19.6 | 13.24 | Upgrade
|
| Operating Income | -5.5 | -7.66 | -10.23 | -26.9 | -11 | -10.72 | Upgrade
|
| Interest Expense | -0.52 | -1.02 | -2.39 | -0.57 | -4.22 | -0.52 | Upgrade
|
| Interest & Investment Income | 0.05 | 0.05 | 0.02 | 0 | - | 0.01 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | - | - | - | 0.01 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.94 | -0 | 2.04 | -0.02 | 0.19 | 1.88 | Upgrade
|
| EBT Excluding Unusual Items | -5.03 | -8.64 | -10.56 | -27.5 | -15.03 | -9.34 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | -1.68 | - | - | Upgrade
|
| Impairment of Goodwill | - | - | - | -1.02 | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -0.2 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.04 | 0.04 | 1.59 | 0.02 | - | - | Upgrade
|
| Asset Writedown | - | - | - | -15.35 | - | - | Upgrade
|
| Pretax Income | -4.98 | -8.59 | -8.97 | -45.72 | -15.03 | -9.34 | Upgrade
|
| Income Tax Expense | - | - | - | - | - | -0.06 | Upgrade
|
| Net Income | -4.98 | -8.59 | -8.97 | -45.72 | -15.03 | -9.28 | Upgrade
|
| Net Income to Common | -4.98 | -8.59 | -8.97 | -45.72 | -15.03 | -9.28 | Upgrade
|
| Shares Outstanding (Basic) | 547 | 463 | 235 | 152 | - | 22 | Upgrade
|
| Shares Outstanding (Diluted) | 547 | 463 | 235 | 152 | - | 22 | Upgrade
|
| Shares Change (YoY) | 55.48% | 97.23% | 54.17% | - | - | 31.55% | Upgrade
|
| EPS (Basic) | -0.01 | -0.02 | -0.04 | -0.30 | - | -0.42 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.02 | -0.04 | -0.30 | - | -0.42 | Upgrade
|
| Free Cash Flow | -0.59 | 0.89 | -9.76 | -20.56 | -16.77 | -10.28 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | 0.00 | -0.04 | -0.14 | - | -0.46 | Upgrade
|
| Gross Margin | 63.25% | 58.96% | 50.54% | 16.12% | 45.62% | 43.35% | Upgrade
|
| Operating Margin | -37.45% | -68.79% | -97.13% | -231.32% | -58.35% | -185.00% | Upgrade
|
| Profit Margin | -33.97% | -77.19% | -85.15% | -393.16% | -79.72% | -160.16% | Upgrade
|
| Free Cash Flow Margin | -4.01% | 8.03% | -92.67% | -176.78% | -88.96% | -177.36% | Upgrade
|
| EBITDA | -4.76 | -6.97 | -9.07 | -25.67 | -10.69 | -10.42 | Upgrade
|
| EBITDA Margin | -32.45% | -62.64% | -86.10% | -220.70% | -56.70% | -179.73% | Upgrade
|
| D&A For EBITDA | 0.74 | 0.69 | 1.16 | 1.24 | 0.31 | 0.31 | Upgrade
|
| EBIT | -5.5 | -7.66 | -10.23 | -26.9 | -11 | -10.72 | Upgrade
|
| EBIT Margin | -37.45% | -68.79% | -97.13% | -231.32% | -58.35% | -185.00% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.